Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
First Claim
Patent Images
1. A method for forming a covalent linkage having structure CH═
- N--RA --CH2, CH2 --RA --N═
CH, or RA --N═
CH--CH2 where RA is O or NR1, comprising the steps of;
(a) providing synthons having structure;
##STR4## (b) contacting said synthons for a time and under reaction conditions effective to form said covalent linkage;
wherein;
Z1 and Y2 are selected such that(i) Z1 is C(O)H and Y2 is CH2 RA NH2 ;
or(ii) Z1 is CH2 RA NH2 and Y2 is C(O)H;
(iii) Z1 is CH2 C(O)H and Y2 is RA NH2 ;
or(iv) Z1 is RA NH2 and Y2 is H(O)CCH2 ;
R1 and R2 are the same or different and are H;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkenyl or substituted alkenyl having 2 to about 10 carbon atoms;
alkynyl or substituted alkynyl having 2 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
alicyclic;
heterocyclic;
a reporter molecule;
BX1 and BX2 are, independently, nucleosidic bases;
Q1 and Q2 are, independently, O, S, CH2, CHF or CF2 ; and
X1 and X2 are, independently, H;
OH;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
F;
Cl;
Br;
CN;
CF3 ;
OCF3 ;
OCN;
O-alkyl;
S-alkyl;
N-alkyl;
O-alkenyl;
S-alkenyl;
N-alkenyl;
SOCH3 ;
SO2 CH3 ;
ONO2 ;
NO2 ;
N3 ;
NH2 ;
heterocycloalkyl;
heterocycloalkaryl;
aminoalkylamino;
polyalkylamino or substituted silyl.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods for preparing oligonucleotide analogs which have improved nuclease resistance and improved cellular uptake are provided. In preferred embodiments, the methods involve reductive coupling of 3'"'"'- and 4'"'"'- substituted or 4'"'"'- and 3'"'"'-substituted nucleosidic synthons.
27 Citations
23 Claims
-
1. A method for forming a covalent linkage having structure CH═
- N--RA --CH2, CH2 --RA --N═
CH, or RA --N═
CH--CH2 where RA is O or NR1, comprising the steps of;(a) providing synthons having structure;
##STR4## (b) contacting said synthons for a time and under reaction conditions effective to form said covalent linkage;wherein; Z1 and Y2 are selected such that (i) Z1 is C(O)H and Y2 is CH2 RA NH2 ;
or(ii) Z1 is CH2 RA NH2 and Y2 is C(O)H; (iii) Z1 is CH2 C(O)H and Y2 is RA NH2 ;
or(iv) Z1 is RA NH2 and Y2 is H(O)CCH2 ; R1 and R2 are the same or different and are H;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkenyl or substituted alkenyl having 2 to about 10 carbon atoms;
alkynyl or substituted alkynyl having 2 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
alicyclic;
heterocyclic;
a reporter molecule;BX1 and BX2 are, independently, nucleosidic bases; Q1 and Q2 are, independently, O, S, CH2, CHF or CF2 ; and X1 and X2 are, independently, H;
OH;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
F;
Cl;
Br;
CN;
CF3 ;
OCF3 ;
OCN;
O-alkyl;
S-alkyl;
N-alkyl;
O-alkenyl;
S-alkenyl;
N-alkenyl;
SOCH3 ;
SO2 CH3 ;
ONO2 ;
NO2 ;
N3 ;
NH2 ;
heterocycloalkyl;
heterocycloalkaryl;
aminoalkylamino;
polyalkylamino or substituted silyl. - View Dependent Claims (2, 3, 4, 5, 6, 7)
- N--RA --CH2, CH2 --RA --N═
-
8. A method for forming a covalent linkage having structure CH2 --NR1 --RA --CH2, CH2 --RA --NR1 --CH2, RA --NR1 --CH2 --CH2, or NR1 --RA --CH2 --CH2, where RA is O or NR2, comprising the steps of:
-
(a) providing synthons having structures;
##STR5## (b) contacting said synthons for a time and under reaction conditions effective to form an intermediate linkage; and(c) reducing said intermediate linkage to form said covalent linkage; wherein; Z1 and Y2 are selected such that (i) Z1 is C(O)H and Y2 is CH2 RA NH2 ;
or(ii) Z1 is CH2 RA NH2 and Y2 is C(O)H; (iii) Z1 is CH2 C(O)H and Y2 is RA NH2 ;
or(iv) Z1 is RA NH2 and Y2 is H(O)CCH2 ; R1 and R2 are, independently, H;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkenyl or substituted alkenyl having 2 to about 10 carbon atoms;
alkynyl or substituted alkynyl having 2 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
alicyclic;
heterocyclic;
a reporter molecule;BX1 and BX2 are, independently, nucleosidic bases; Q1 and Q2 are, independently, O, S, CH2, CHF or CF2 ; and X1 and X2 are, independently, H;
OH;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
F;
Cl;
Br;
CN;
CF3 ;
OCF3 ;
OCN;
O-alkyl;
S-alkyl;
N-alkyl;
O-alkenyl;
S-alkenyl;
N-alkenyl;
SOCH3 ;
SO2 CH3 ;
ONO2 ;
NO2 ;
N3 ;
NH2 ;
heterocycloalkyl;
heterocycloalkaryl;
aminoalkylamino;
polyalkylamino or substituted silyl. - View Dependent Claims (9, 10, 11, 12, 13, 14)
-
-
15. A compound having structure:
- ##STR6## wherein;
Z1 is C(O)H, CH2 C(O)H, CH2 RA NH2, or RA NH2 ;RA is O or NR1 ; Y1 is hydroxymethyl, a nucleoside, a nucleotide, an oligonucleotide, an oligonucleoside, or a hydroxyl-protected or amine-protected derivative thereof; R1 is H;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkenyl or substituted alkenyl having 2 to about 10 carbon atoms;
alkynyl or substituted alkynyl having 2 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
alicyclic;
heterocyclic;
a reporter molecule;BX1 is a nucleosidic base; Q1 is O, S, CH2, CHF or CF2 ; and X1 is H;
OH;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
F;
Cl;
Br;
CN;
CF3 ;
OCF3 ;
OCN;
O-alkyl;
S-alkyl;
N-alkyl;
O-alkenyl;
S-alkenyl;
N-alkenyl;
SOCH3 ;
SO2 CH3 ;
ONO2 ;
NO2 ;
N3 ;
NH2 ;
heterocycloalkyl;
heterocycloalkaryl;
aminoalkylamino;
polyalkylamino or substituted silyl. - View Dependent Claims (16, 17, 18, 19)
- ##STR6## wherein;
-
20. A compound having structure:
- ##STR7## wherein;
Y2 is C(O)H, CH2 C(O)H, CH2 RA NH2, or RA NH2 ;RA is O or NR2 ; Z2 is hydroxymethyl, a nucleoside, a nucleotide, an oligonucleotide, an oligonucleoside, or a hydroxyl-protected or amine-protected derivative thereof; R1 is H;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkenyl or substituted alkenyl having 2 to about 10 carbon atoms;
alkynyl or substituted alkynyl having 2 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
alicyclic;
heterocyclic;
a reporter molecule;BX1 is a nucleoside base; Q1 is O, S, CH2, CHF or CF2 ; and X2 is H;
OH;
alkyl or substituted alkyl having 1 to about 10 carbon atoms;
alkaryl, substituted alkaryl, aralkyl, or substituted aralkyl having 7 to about 14 carbon atoms;
F;
Cl;
Br;
CN;
CF3 ;
OCF3 ;
OCN;
O-alkyl;
S-alkyl;
N-alkyl;
O-alkenyl;
S-alkenyl;
N-alkenyl;
SOCH3 ;
SO2 CH3 ;
ONO2 ;
NO2 ;
N3 ;
NH2 ;
heterocycloalkyl;
heterocycloalkaryl;
aminoalkylamino;
polyalkylamino or substituted silyl. - View Dependent Claims (21, 22, 23)
- ##STR7## wherein;
Specification